{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:41:01Z","timestamp":1788320461431,"version":"build-2803163510"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>The emergence and global impact of COVID-19 has focused the scientific and medical community on the pivotal influential role of respiratory viruses as causes of severe pneumonia, on the understanding of the underlying pathomechanisms, and on potential treatment for COVID-19. The latter concentrates on<jats:italic>four<\/jats:italic>different strategies: (i) antiviral treatments to limit the entry of the virus into the cell and its propagation, (ii) anti-inflammatory treatment to reduce the impact of COVID-19 associated inflammation and cytokine storm, (iii) treatment using cardiovascular medication to reduce COVID-19 associated thrombosis and vascular damage, and (iv) treatment to reduce the COVID-19 associated lung injury. Ideally, effective COVID-19 treatment should target as many of these mechanisms as possible arguing for the search of common denominators as potential drug targets. Leukotrienes and their receptors qualify as such targets: they are lipid mediators of inflammation and tissue damage and well-established targets in respiratory diseases like asthma. Besides their role in inflammation, they are involved in various other aspects of lung pathologies like vascular damage, thrombosis, and fibrotic response, in brain and retinal damages, and in cardiovascular disease. In consequence, leukotriene receptor antagonists might be potential candidates for COVID-19 therapeutics. This review summarizes the current knowledge on the potential involvement of leukotrienes in COVID-19, and the rational for the use of the leukotriene receptor antagonist montelukast as a COVID-19 therapeutic.<\/jats:p>","DOI":"10.3389\/fmolb.2020.610132","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T20:48:35Z","timestamp":1610052515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic"],"prefix":"10.3389","volume":"7","author":[{"given":"Ludwig","family":"Aigner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Pietrantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Marisa","family":"Bessa de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Anton","family":"Reitsamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Zerbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Studnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/ejcts\/ezs312","article-title":"Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats","volume":"43","author":"Al-Amran","year":"2013","journal-title":"Eur. J. Cardiothorac. Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.thromres.2020.05.039","article-title":"Thrombosis risk associated with COVID-19 infection. a scoping review","volume":"192","author":"Al-Ani","year":"2020","journal-title":"Thromb. Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1378\/chest.07-0831","article-title":"The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics","volume":"132","author":"Allayee","year":"2007","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"109883","DOI":"10.1016\/j.mehy.2020.109883","article-title":"The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast","volume":"143","author":"Almerie","year":"2020","journal-title":"Med. Hypotheses"},{"key":"B5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1476-5381.2008.00012.x","article-title":"Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism","volume":"156","author":"Anderson","year":"2009","journal-title":"Br. J. Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"116832","DOI":"10.1016\/j.jns.2020.116832","article-title":"Central nervous system manifestations of COVID-19: a systematic review","volume":"413","author":"Asadi-Pooya","year":"2020","journal-title":"J. Neurol. Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1111\/bph.12665","article-title":"Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR review 7","volume":"171","author":"Back","year":"2014","journal-title":"Br. J. Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem. Neurosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1073\/pnas.1605957113","article-title":"Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99","volume":"113","author":"Bankova","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.2337\/db19-0026","article-title":"Montelukast prevents early diabetic retinopathy in Mice","volume":"68","author":"Bapputty","year":"2019","journal-title":"Diabetes"},{"key":"B11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","article-title":"COVID-19 update: covid-19-associated coagulopathy","volume":"50","author":"Becker","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.0400235101","article-title":"Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis","volume":"101","author":"Beller","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2310\/JIM.0b013e3181fa02f7","article-title":"Airway platelet activation is associated with airway eosinophilic inflammation in asthma","volume":"58","author":"Benton","year":"2010","journal-title":"J. Investig. Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fncel.2018.00386","article-title":"Neurologic alterations due to respiratory virus infections","volume":"12","author":"Bohmwald","year":"2018","journal-title":"Front. Cell. Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1164\/rccm.200501-034OC","article-title":"5-Lipoxygenase deficiency prevents respiratory failure during ventilator-induced lung injury","volume":"172","author":"Caironi","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1006140","DOI":"10.1371\/journal.ppat.1006140","article-title":"Alveolar macrophages prevent lethal influenza pneumonia by inhibiting infection of type-1 alveolar epithelial cells","volume":"13","author":"Cardani","year":"2017","journal-title":"PLoS Pathog"},{"key":"B17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin. Immunopathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.3389\/fmicb.2019.03079","article-title":"Montelukast, an anti-asthmatic drug, inhibits zika virus infection by disrupting viral integrity","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","article-title":"The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor","volume":"25","author":"Ciana","year":"2006","journal-title":"EMBO J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1128\/JVI.03488-13","article-title":"Coronaviruses: important emerging human pathogens","volume":"88","author":"Coleman","year":"2014","journal-title":"J. Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2020.05.013","article-title":"Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface","author":"Collin","year":"2020","journal-title":"Ocul. Surf."},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.4049\/jimmunol.1302187","article-title":"Cutting edge: leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor","volume":"191","author":"Cummings","year":"2013","journal-title":"J. Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.arbres.2019.05.003","article-title":"Montelukast leukotriene inhibitor, reduces LPS-induced acute lung inflammation and human neutrophil activation","volume":"55","author":"Davino-Chiovatto","year":"2019","journal-title":"Arch. Bronconeumol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group","volume":"87","author":"de Groot","year":"2013","journal-title":"J. Virol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbrc.2017.02.125","article-title":"Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: an implication for the treatment of atherosclerosis","volume":"486","author":"Di","year":"2017","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1586\/eci.09.62","article-title":"Montelukast in the treatment of asthma and beyond","volume":"5","author":"Diamant","year":"2009","journal-title":"Expert Rev. Clin. Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br. J. Haematol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","article-title":"Endothelial dysfunction in COVID-19: a position paper of the esc working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science","volume":"116","author":"Evans","year":"2020","journal-title":"Cardiovasc. Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"109828","DOI":"10.1016\/j.mehy.2020.109828","article-title":"As a potential treatment of COVID-19: montelukast","volume":"142","author":"Fidan","year":"2020","journal-title":"Med. Hypotheses"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e58305","DOI":"10.1371\/journal.pone.0058305","article-title":"Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes","volume":"8","author":"Foster","year":"2013","journal-title":"PLoS ONE"},{"key":"B33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 States, March 1-30, 2020","volume":"69","author":"Garg","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.phrs.2019.02.025","article-title":"Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug","volume":"142","author":"Gelosa","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"China medical treatment expert group for, clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e00341","DOI":"10.1002\/prp2.341","article-title":"Adverse drug reactions of montelukast in children and adults","volume":"5","author":"Haarman","year":"2017","journal-title":"Pharmacol. Res. Perspect"},{"key":"B37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1164\/rccm.200912-1811OC","article-title":"Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus","volume":"182","author":"Han","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","article-title":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme","volume":"532","author":"Harmer","year":"2002","journal-title":"FEBS Lett"},{"key":"B39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/09537101003615394","article-title":"Functional expression of cysteinyl leukotriene receptors on human platelets","volume":"21","author":"Hasegawa","year":"2010","journal-title":"Platelets"},{"key":"B40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2332\/allergolint.O-06-473","article-title":"Clinical evaluation of leukotriene receptor antagonists in preventing common cold-like symptoms in bronchial asthma patients","volume":"56","author":"Horiguchi","year":"2007","journal-title":"Allergol. Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jaci.2011.11.052","article-title":"Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease","volume":"129","author":"Ingelsson","year":"2012","journal-title":"J. Allergy Clin. Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/IJPM.IJPM_280_20","article-title":"COVID-19 and lung pathology","volume":"63","author":"Jain","year":"2020","journal-title":"Indian J. Pathol. Microbiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1183\/09031936.02.00244602","article-title":"Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma","volume":"20","author":"Kanniess","year":"2002","journal-title":"Eur. Respir. J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1139\/cjpp-2014-0191","article-title":"Montelukast reduces sepsis-induced lung and renal injury in rats","volume":"92","author":"Khodir","year":"2014","journal-title":"Can. J. Physiol. Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1365-2222.2006.02446.x","article-title":"Platelet activation in allergic asthma patients during allergen challenge with dermatophagoides pteronyssinus","volume":"36","author":"Kowal","year":"2006","journal-title":"Clin. Exp. Allergy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.23812\/20-Editorial-Kritas","article-title":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy","volume":"34","author":"Kritas","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00417-020-04641-8","article-title":"Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong","volume":"258","author":"Lai","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"101695","DOI":"10.1016\/j.pneurobio.2019.101695","article-title":"Platelets: the missing link between the blood and brain?","volume":"183","author":"Leiter","year":"2019","journal-title":"Prog. Neurobiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neuroscience.2014.07.058","article-title":"Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction","volume":"277","author":"Lenz","year":"2014","journal-title":"Neuroscience"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jmii.2016.04.005","article-title":"Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages","volume":"51","author":"Lin","year":"2018","journal-title":"J. Microbiol. Immunol. Infect"},{"key":"B56","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.4049\/jimmunol.1402959","article-title":"Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors","volume":"194","author":"Liu","year":"2015","journal-title":"J. Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/09537104.2020.1754383","article-title":"Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study","volume":"31","author":"Liu","year":"2020","journal-title":"Platelets"},{"key":"B58","doi-asserted-by":"publisher","first-page":"145561320920762","DOI":"10.1177\/0145561320920762","article-title":"Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms","volume":"99","author":"Lovato","year":"2020","journal-title":"Ear Nose Throat J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S1081-1206(10)61326-9","article-title":"Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules","volume":"94","author":"Maeba","year":"2005","journal-title":"Ann. Allergy Asthma Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2450\/2020.0083-20","article-title":"COVID-19 and haemostasis: a position paper from Italian society on thrombosis and haemostasis (SISET)","volume":"18","author":"Marietta","year":"2020","journal-title":"Blood Transfus"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/S0140-6736(20)31014-X","article-title":"Retinal findings in patients with COVID-19","volume":"395","author":"Marinho","year":"2020","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1517\/14728222.2013.837886","article-title":"Targeting CCL5 in inflammation","volume":"17","author":"Marques","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s13311-020-00836-3","article-title":"The leukotriene receptor antagonist montelukast reduces alpha-synuclein load and restores memory in an animal model of dementia with lewy bodies","volume":"17","author":"Marschallinger","year":"2020","journal-title":"Neurotherapeutics"},{"key":"B66","doi-asserted-by":"publisher","first-page":"8466","DOI":"10.1038\/ncomms9466","article-title":"Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug","volume":"6","author":"Marschallinger","year":"2015","journal-title":"Nat. Commun"},{"key":"B67","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1053\/prrv.2001.0146","article-title":"Leukotrienes in respiratory disease","volume":"2","author":"McMillan","year":"2001","journal-title":"Paediatr. Respir. Rev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"Across speciality collaboration, COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"105921","DOI":"10.1016\/j.clineuro.2020.105921","article-title":"Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review","volume":"194","author":"Montalvan","year":"2020","journal-title":"Clin. Neurol. Neurosurg"},{"key":"B71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/FPC.0b013e32831bd98c","article-title":"Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response","volume":"19","author":"Mougey","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"B72","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/0091270010374472","article-title":"Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast","volume":"51","author":"Mougey","year":"2011","journal-title":"J. Clin. Pharmacol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/ene.14277","article-title":"Does SARS-Cov-2 invade the brain? Translational lessons from animal models","volume":"27","author":"Natoli","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3233\/JAD-200537","article-title":"Potential novel role of COVID-19 in alzheimer's disease and preventative mitigation strategies","volume":"76","author":"Naughton","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/JVI.00737-08","article-title":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","volume":"82","author":"Netland","year":"2008","journal-title":"J. Virol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bbrc.2005.09.052","article-title":"Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods","volume":"337","author":"Nonaka","year":"2005","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1183\/09031936.98.11061232","article-title":"Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group","volume":"11","author":"Noonan","year":"1998","journal-title":"Eur. Respir. J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1124\/mol.58.6.1601","article-title":"Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist","volume":"58","author":"Nothacker","year":"2000","journal-title":"Mol. Pharmacol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1007\/s11095-008-9642-z","article-title":"Dynamic dissolution testing to establish in vitro\/in vivo correlations for montelukast sodium, a poorly soluble drug","volume":"25","author":"Okumu","year":"2008","journal-title":"Pharm. Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.bbagen.2011.02.005","article-title":"Leukotrienes and airway inflammation","volume":"1810","author":"Okunishi","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"B81","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/2040622310383343","article-title":"Montelukast in asthma: a review of its efficacy and place in therapy","volume":"2","author":"Paggiaro","year":"2011","journal-title":"Ther. Adv. Chronic Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11882-008-0057-z","article-title":"Expanding roles for leukotrienes in airway inflammation","volume":"8","author":"Peters-Golden","year":"2008","journal-title":"Curr. Allergy Asthma Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N. Engl. J. Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.1148\/radiol.2020201187","article-title":"COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features","volume":"2","author":"Poyiadji","year":"2020","journal-title":"Radiology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/all.13789","article-title":"Leukotriene B4 receptors mediate the production of IL-17, thus contributing to neutrophil-dominant asthmatic airway inflammation","volume":"74","author":"Ro","year":"2019","journal-title":"Allergy"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3332\/ecancer.2020.1022","article-title":"Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence","volume":"14","author":"Russell","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.rmed.2013.09.006","article-title":"Inhibitory effects of Montelukast on mediator release by nasal epithelial cells from asthmatic subjects with or without allergic rhinitis","volume":"107","author":"Scaife","year":"2013","journal-title":"Respir. Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2125.1995.tb05785.x","article-title":"Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers","volume":"40","author":"Schoors","year":"1995","journal-title":"Br. J. Clin. Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu. Rev. Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1164\/rccm.201301-0023PP","article-title":"Antileukotriene agents for the treatment of lung disease","volume":"188","author":"Scott","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1101\/2020.06.03.20112540","article-title":"Acute vision loss in a patient with COVID-19","volume":"103","author":"Selvaraj","year":"2020","journal-title":"R. I. Med. J"},{"key":"B92","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","article-title":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","volume":"20","author":"Shi","year":"2020","journal-title":"Lancet Infect. Dis"},{"key":"B93","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1002\/j.1875-9114.1997.tb03701.x","article-title":"The use of 5-lipoxygenase inhibitors and leukotriene receptor antagonists in the treatment of chronic asthma","volume":"17","author":"Sorkness","year":"1997","journal-title":"Pharmacotherapy"},{"key":"B94","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S1081-1206(10)61156-8","article-title":"Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis","volume":"95","author":"Stelmach","year":"2005","journal-title":"Ann. Allergy Asthma Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2222.2001.00969.x","article-title":"Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years","volume":"31","author":"Storms","year":"2001","journal-title":"Clin. Exp. Allergy"},{"key":"B96","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1378\/chest.127.2.509","article-title":"The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old","volume":"127","author":"Straub","year":"2005","journal-title":"Chest"},{"key":"B97","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/jcmm.12727","article-title":"P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma","volume":"20","author":"Suh","year":"2016","journal-title":"J. Cell. Mol. Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1159\/000067466","article-title":"Platelet dynamics following allergen challenge in allergic asthmatics","volume":"67","author":"Sullivan","year":"2000","journal-title":"Respiration"},{"key":"B99","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1365-2222.2008.02963.x","article-title":"Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity","volume":"38","author":"Tahan","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"B100","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1006\/bbrc.2000.3140","article-title":"The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor","volume":"274","author":"Takasaki","year":"2000","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"B101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2500\/aap.2016.37.3978","article-title":"Effect of montelukast on markers of airway remodeling in children with asthma","volume":"37","author":"Tenero","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"B102","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am. J. Hematol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/biof.1633","article-title":"COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin","volume":"46","author":"Theoharides","year":"2020","journal-title":"Biofactors"},{"key":"B104","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fphar.2016.00299","article-title":"Cysteinyl leukotrienes pathway genes, atopic asthma and drug response: from population isolates to large genome-wide association studies","volume":"7","author":"Thompson","year":"2016","journal-title":"Front. Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1111\/jcmm.14239","article-title":"The synergistic effects of clopidogrel with montelukast may be beneficial for asthma treatment","volume":"23","author":"Trinh","year":"2019","journal-title":"J. Cell. Mol. Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B107","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3760\/cma.j.cn501120-20200307-00132","article-title":"[Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures]","volume":"36","author":"Wang","year":"2020","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.4049\/jimmunol.1100333","article-title":"Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis","volume":"187","author":"Wang","year":"2011","journal-title":"J. Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1007\/s00415-020-09974-2","article-title":"Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis","volume":"267","author":"Wang","year":"2020","journal-title":"J. Neurol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"L1143","DOI":"10.1152\/ajplung.00323.2001","article-title":"Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus","volume":"282","author":"Wedde-Beer","year":"2002","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1177\/0300060518820412","article-title":"Effect of montelukast combined with methylprednisolone for the treatment of mycoplasma pneumonia","volume":"47","author":"Wu","year":"2019","journal-title":"J. Int. Med. Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/jamaophthalmol.2020.1291","article-title":"Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China","volume":"138","author":"Wu","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72314 cases from the chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00277-020-04019-0","article-title":"Mechanism of thrombocytopenia in COVID-19 patients","volume":"99","author":"Xu","year":"2020","journal-title":"Ann. Hematol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00259-020-04735-9","article-title":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2","volume":"47","author":"Xu","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1172\/JCI97946","article-title":"Leukotriene receptors as potential therapeutic targets","volume":"128","author":"Yokomizo","year":"2018","journal-title":"J. Clin. Invest"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00701-020-04374-x","article-title":"SARS-CoV-2 can induce brain and spine demyelinating lesions","volume":"162","author":"Zanin","year":"2020","journal-title":"Acta Neurochir."},{"key":"B119","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.intimp.2018.06.006","article-title":"Cangrelor alleviates pulmonary fibrosis by inhibiting GPR17-mediated inflammation in mice","volume":"62","author":"Zhan","year":"2018","journal-title":"Int. Immunopharmacol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B121","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.thromres.2020.06.008","article-title":"Mechanisms involved in the development of thrombocytopenia in patients with COVID-19","volume":"193","author":"Zhang","year":"2020","journal-title":"Thromb. Res"},{"key":"B122","doi-asserted-by":"publisher","first-page":"101642","DOI":"10.1016\/j.tmaid.2020.101642","article-title":"Sars-Cov-2: underestimated damage to nervous system","volume":"36","author":"Zhou","year":"2020","journal-title":"Travel Med. Infect. Dis"},{"key":"B123","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2020.610132\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T00:39:24Z","timestamp":1698539964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2020.610132\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":123,"alternative-id":["10.3389\/fmolb.2020.610132"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2020.610132","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]},"article-number":"610132"}}